2.8 C
Glasgow
Tuesday, February 3, 2026
spot_img

More News

Lilly injectable medicine and device manufacturing facility to be built in Pennsylvania

Jim Cornall -
Eli Lilly and Company has announced plans to invest more than $3.5bn in a new manufacturing facility in the...

A broken DNA repair tool accelerates aging

Jim Cornall -
Although DNA is tightly packed and protected within the cell nucleus, it is constantly threatened by damage from normal...

Base to Base biotech podcast 44: Treating breast cancer and how a CDMO and immuno-oncology company collaborate

Jim Cornall -
This week, we chat with Pan Cancer T CEO Dr. Rachel Abbott, about – among other things – triple-negative...

Two-faced nanoparticles help antibiotics treat resistant bacteria

Jim Cornall -
In the global battle against antimicrobial resistance (AMR), an international research team has unveiled what it says is a...

Resolve M Therapeutics exits from stealth

Jim Cornall -
Resolve M Therapeutics, Inc. has announced its exit from stealth. Resolve M was created through a strategic collaboration between...

New cancer treatment options through expanding ADC payload spectrum

Jim Cornall -
Tubulis has published preclinical proof-of-concept data for its novel Alco5 conjugation platform in Nature Communications. The paper, Expanding the payload...

Why tumours become aggressive and genetically unstable

Jim Cornall -
A new study shows that cancer damages its own DNA by pushing key genes to work too hard. Cancer cells...

DIA launches platform to boost drug development

Jim Cornall -
The Drug Information Association (DIA) has launched DIA ASCENT, a new global platform designed to support early-stage biotechnology drug...

Nanoscope boosts retina gene therapy in Japan

Jim Cornall -
Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, has announced that...

Ouro Medicines receives Fast Track Designation for gamgertamig

Jim Cornall -
Ouro Medicines, which is developing immune reset therapeutics for people living with chronic, immune-mediated diseases, has announced that gamgertamig,...

Infinitopes raises more funds for precision cancer vaccine

Jim Cornall -
Infinitopes, a clinical-stage cancer vaccine biotechnology company, has completed the second close of its seed financing round, securing an...

Women in Life Science Denmark expands with launch of WiLD Finland

Jim Cornall -
Women in Life Science Denmark (WiLD), the Nordic non-profit network dedicated to advancing women into senior leadership positions in...

Lilly platinum-resistant ovarian cancer drug receives U.S. FDA’s Breakthrough Therapy designation

Jim Cornall -
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation...

How cancer cells protect themselves from the immune system

Jim Cornall -
An international research team has succeeded in deciphering a key mechanism that controls the growth of pancreatic cancers. The...

Zaire ebolavirus vaccine development advancing

Jim Cornall -
SK bioscience is advancing the development of a Zaire ebolavirus vaccine under a new collaboration supported by the Coalition...

Base to Base biotech podcast 43: Natural killer cell therapy and attacking tumours

Jim Cornall -
This week, we have a conversation with Lisa Guerrettaz, executive director, Pharmacology and Translational Science at Artiva Biotherapeutics; and...

Brainomix e-Lung AI imaging technology selected in Boehringer Ingelheim pulmonary fibrosis trial

Jim Cornall -
Brainomix has announced it was selected by Boehringer Ingelheim to provide objective, quantitative HRCT imaging biomarkers as a co-primary...

Scientists uncover hidden cells fuelling brain cancer — and a drug that could stop them

Jim Cornall -
A team of Canadian scientists has uncovered a new way to slow the growth of glioblastoma, the most aggressive...

Wiskott-Aldrich syndrome treatment approved

Jim Cornall -
With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for...

Positive phase 3 results from insomnia trial

Jim Cornall -
Nxera Pharma Co., Ltd. has announced positive top-line results from a phase 3 study in South Korea evaluating daridorexant...

AbbVie announces topline results for phase 3 lymphoma trial

Jim Cornall -
AbbVie has announced topline results from its phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody...

Deeptech Digest is your guide to what's new in at the cutting edge of science technology. A bit of artificial intelligence, some biotech, and all the news and latests developments in the field. If it's deeptech, it's in Deeptech Digest!

Contact us: jim@deeptechdigest.com

© 2023 Ayr Coastal Media